Min Deng is a postdoctoral fellow in the Department of Molecular Cell Biology, Center for Cancer Cell Reprogramming. He earned his Ph.D. in biomedical science from Maastricht University in 2023. During his Ph.D. studies, Min concentrated on exploring the influence of immune system activation and tumor-derived factors on the development of cancer cachexia. His research interests include gaining a mechanistic understanding of systemic inflammation and the processes of fat and muscle degradation in cancer-associated cachexia. Within MORGI, he aims to establish a multi-tissue system to model cachexia and delve into the mechanisms of tumor-host interactions and cancer cachexia using induced pluripotent stem cell-derived organoids.
Min Deng
Postdoctoral Fellow
-
Centre for Cancer Cell Reprogramming
Norwegian version of this page
Email
min.deng@medisin.uio.no
Username
Visiting address
Ullernchausséen 70
0379 Oslo
Postal address
Postboks 4950
0424 Oslo
Selected publications
Deng, Min, Jianhua Cao, Gregory van der Kroft, David PJ van Dijk, Merel R. Aberle, Andrej Grgic, Ulf P. Neumann et al. "Inflammationâassociated intramyocellular lipid alterations in human pancreatic cancer cachexia." Journal of cachexia, sarcopenia and muscle (2024).
Deng, Min, Merel R. Aberle, Annemarie AJHM van Bijnen, Gregory van der Kroft, Kaatje Lenaerts, Ulf P. Neumann, Georg Wiltberger, Frank G. Schaap, Steven WM Olde Damink, and Sander S. Rensen. "Lipocalin-2 and neutrophil activation in pancreatic cancer cachexia." Frontiers in Immunology 14 (2023): 1159411.
Deng, Min, Rianne DW Vaes, Annemarie AJHM van Bijnen, Steven WM Olde Damink, and Sander S. Rensen. "Activation of the complement system in patients with cancer cachexia." Cancers 13, no. 22 (2021): 5767.
Published
Apr. 4, 2023 2:04 PM
- Last modified
July 2, 2024 10:27 PM